Azka Ali, MD

Breast Medical Oncologist @clevelandclinic Taussig Can Inst. | Interested in experimental therapeutics #bcsm | @hemeoncgators and @MUSC_COM alum. Views = me

[Layla Abushamat @LaylaAbushamat]

Check out our @JACCJournals editorial (https://t.co/ERcXwTjEaE) on the FOURIER Prespecified Analysis showing obesity-associated benefit from PCSK9i, evolocumab (https://t.co/yhoqa2pNA8). @CBallantyneMD @arsalanhamid93 @vijay_nambi @hwubcm

[Jame Abraham, MD, FACP @jamecancerdoc]

It is a beautiful day in #cleveland ⁦@bikeVeloSano⁩ ⁦@ClevelandClinic⁩ !

[Azka Ali, MD @AzkaAliMD]

Thanks @ZunairahShah for moderating a wonderful session

[Zunairah Shah @ZunairahShah]

Amazing educational webinar by Dr. Ali @AzkaAliMD on ADCs in HR+ MBC with evidence, nuance, and real-world tips.

[DAVA Oncology @DAVAOnc]

Dr. @AzkaAliMD (@ClevelandClinic) shares how CNN-based AI models (e.g., IbRiS) applied to H&E slides predict DFS/OS in ER+ breast cancer; retrospectively validated across U.S. & India cohorts. Outperforms Oncotype in ILC & Black pts. Scalable, low-cost risk tool. #DAVABreast

[DAVA Oncology @DAVAOnc]

USP1 regulates replication fork stability. Dr. @AzkaAliMD (@ClevelandClinic) highlights KSQi (RO7623066) as a USP1i that synergizes with Olaparib. Tumor regressions seen in BRCA1+ mBC; PK and biomarker data support continued study. #DAVABreast

[Sobia Laique MD @SNLaiqueMD]

Dr. Shreya Sengupta was a gifted clinician, rising health services researcher, and fierce advocate for the most vulnerable. Her work transformed ALD care and advanced equity in hepatology.

Thank you @AASLDtweets for honoring her legacy. Donate: https://t.co/H0ZGTAaJyf

[Mark Lewis, MD, FASCO @marklewismd]

It's been exactly 20 years since my first day of internship

As I reflect on my disproportionate aging since then (gray hairs >>> wisdom), here are my 10 unsolicited recommendations for any colleague embarking on residency

THE "ATTENDING ADVICE YOU DIDN'T ASK FOR" THREAD ...

[Stephanie Valente @DrStephValente]

9th Annual Cleveland Breast Cancer Summit: Collaborating for a Cure- Friday August 8, 2025. Triple Negative Breast Cancer

https://t.co/JX5j81W3EG

[Oncology News Central @OncNewsCentral]

Slideshow: ADCs like #DatoDXd and next-gen endocrine therapies offer new options—but with more choice comes tougher clinical questions. https://t.co/IH4utZtwgb #BreastCancer #Oncology #ADCs #EndocrineTherapy @jhaveri_komal @ErinCobain @AzkaAliMD @dradityabardia @jrgralow

[Azka Ali, MD @AzkaAliMD]

This!

[Harold J. Burstein, MD, PhD, FASCO @DrHBurstein]

That's the world's literature on ivermectin in advanced cancer. 8 pts with TNBC getting ICI + ivermectin, 1 response (same rate as ICI alone, in other trials), avg PFS of 2.5 m. So, at present, there is no evidence for meaningful clinical activity of ivermectin in cancer.

[Azka Ali, MD @AzkaAliMD]

Honored to accept the Velosano Pilot Award investigating the role of ctDNA in metastatic lobular breast cancer. Thanks to @MeganKruseMD and @StoverLab for their support! @bikeVeloSano @ClevelandClinic @CleClinicMD

[Azka Ali, MD @AzkaAliMD]

So well deserving! Congrats @gt_budd! Amazing colleague, mentor, and friend! @ClevelandClinic @CleClinicMD

[Jame Abraham, MD, FACP @jamecancerdoc]

Please join me in congratulating @gt_budd for receiving the Legacy Coin from @TomMihaljevicMD the President and CEO of @ClevelandClinic ! Dr. Budd embodies the very essence of a @CleClinicMD !!

[Jame Abraham, MD, FACP @jamecancerdoc]

Wonderful to see @ThejusJay featured in @DFarberYoungCRC ! @ccfhemonc @ClevelandClinic @CleClinicMD Alumni!

[Azka Ali, MD @AzkaAliMD]

This!

[Smitha Krishnamurthi @smitha42]

#Cancer is the #1 cause of death in people below the age of 85. There is so much work to do. We need to invest more in @NCI, not less.

[Oncology News Central @OncNewsCentral]

KEYNOTE-522: Exploratory #Biomarker analysis highlights TMB & T-cell-inflamed GEP as linked to better outcomes in early-stage #TripleNegativeBreastCancer. #Pembrolizumab shows efficacy across biomarker-defined subgroups.
https://t.co/yUcSDDF3da @AzkaAliMD #SABCS24 #TNBC

[Jame Abraham, MD, FACP @jamecancerdoc]

Wonderful to see @ClevelandClinic along with other major cancer centers !

[CancerTherapyAdvisor @CancerTherAdvsr]

Advances in early breast cancer from #SABCS24. With @AzkaAliMD and @Haddad_Sara7 of @ClevelandClinic, @MOliveira_MD of @vallhebron, Dr Toralf Reimer of @unirostock, @gandhi_shipra of @RoswellPark, and Dr Sheldon Feldman of @MontefioreNYC. #bcsm https://t.co/NVP9XU5DCC

[Katie Ryba @KatieRyba]

Tune in to the latest @CleClinicMD Cancer Advances podcast! @AzkaAliMD shares insights from #SABCS24 on ESR1 mutations, PI3K pathways, and advancing treatments for HR+/HER2- #breastcancer #CleClinicCancer https://t.co/OT8glfLVcw

[OncLive.com @OncLive]

Thanks so much to @AzkaAliMD, of @clevelandclinic, for sitting down with us at #SABCS24 to speak about alternative chemo dosing schedules in breast cancer! Check out our site for insights from Dr Ali and more! @SABCSSanAntonio #bcsm #oncology
https://t.co/4sGPaMZOcg

[Jame Abraham, MD, FACP @jamecancerdoc]

Congratulations to ⁦@AzkaAliMD⁩ for presenting ⁦@SWOG⁩ S0221 long term follow up data ⁦@SABCSSanAntonio⁩ #sabcs24 ⁦@OncoAlert⁩ ⁦@oncodaily⁩ ⁦@gt_budd⁩ ⁦@CleClinicMD⁩